<div id="readability-page-1"><div><p><span>Chacko Jacob, Chief Executive Officer of Oric Pharmaceuticals Inc [ORIC], filed a Form 144 on December 16, 2025 with the Securities and Exchange Commission proposing to sell restricted securities:</span></p><div><table><tbody><tr><td><span>Approximate Date Of Sale</span></td><td><span>12/16/25</span></td></tr><tr><td><span>Shares</span></td><td><span>33,374</span></td></tr><tr><td><span>Broker</span></td><td><span>E-TRADE Financial</span></td></tr></tbody></table></div><p><span>Prior to the sale of restricted stock, owners must file a Form 144 with the SEC.  Upon submission of the filing to the SEC the owner is permitted to sell the shares, or any fraction thereof, within 90 days.</span></p><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

ORIC

<p>Oric Pharmaceuticals Inc's CEO, Chacko Jacob, filed a Form 144 with the SEC to sell 33,374 restricted shares on December 16, 2025. The sale will be conducted through E-TRADE Financial. Form 144 is required for selling restricted stock, allowing the owner to sell within 90 days of filing.</p>

CEO Chacko Files To Sell 33,374 Of Oric Pharmaceuticals Inc [ORIC]